Market Research Logo

Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T cells directed against a cancer antigen, and lessen factors that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Under the Lm Technology platform, the company has four immunotherapy candidates in development, Axalimogene filolisbac (AXAL) in Human Papilloma Virus (HPV)-associated cancers; Neoantigen Therapy (ADXS-NEO); ADXS-PSA in prostate cancer; and ADXS-HER2 in HER2-expressing solid tumors. Advaxis is headquartered in Princeton, New Jersey, the US.

Advaxis Inc Key Recent Developments

Dec 20,2017: Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update
Dec 12,2017: How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing
Nov 01,2017: Advaxis to Receive $4.5 Million through the New Jersey Economic Development Authority NOL Program
Sep 11,2017: Advaxis Reports Business Update and Third Quarter 2017 Results
Jul 07,2017: Princeton biotech Advaxis CEO and President resigns

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Advaxis Inc - Key Facts 5
Advaxis Inc - Key Employees 6
Advaxis Inc - Key Employee Biographies 7
Advaxis Inc - Major Products and Services 8
Advaxis Inc - History 9
Advaxis Inc - Company Statement 13
Advaxis Inc - Locations And Subsidiaries 14
Head Office 14
Section 2 – Company Analysis 15
Company Overview 15
Advaxis Inc - Business Description 15
Advaxis Inc - Corporate Strategy 16
Advaxis Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Advaxis Inc - Strengths 17
Advaxis Inc - Weaknesses 18
Advaxis Inc - Opportunities 19
Advaxis Inc - Threats 20
Advaxis Inc - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Advaxis Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Dec 20, 2017: Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update 31
Dec 12, 2017: How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing 33
Nov 01, 2017: Advaxis to Receive $4.5 Million through the New Jersey Economic Development Authority NOL Program 35
Sep 11, 2017: Advaxis Reports Business Update and Third Quarter 2017 Results 36
Jul 06, 2017: Advaxis Announces Change in Leadership 38
Jun 13, 2017: Advaxis Details Registrational Trials, EU Regulatory and Commercial Plans at Annual Investor & Analyst Day 39
Jun 01, 2017: Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis' Clinical Trials 42
Apr 19, 2017: Advaxis Appoints Anthony Lombardo as Chief Business Officer 43
Mar 07, 2017: Advaxis Appoints Al Blunt, M.D., as its Vice President of Medical 44
Jan 09, 2017: Advaxis Provides 2017 Business Outlook 45
Section 6 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52
List of Tables
Advaxis Inc, Key Facts 5
Advaxis Inc, Key Employees 6
Advaxis Inc, Key Employee Biographies 7
Advaxis Inc, Major Products and Services 8
Advaxis Inc, History 9
Advaxis Inc, Key Competitors 21
Advaxis Inc, Ratios based on current share price 22
Advaxis Inc, Annual Ratios 23
Advaxis Inc, Annual Ratios (Cont...1) 24
Advaxis Inc, Interim Ratios 26
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Advaxis Inc, Recent Deals Summary 30
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51
List of Figures
Advaxis Inc, Performance Chart (2013 - 2017) 25
Advaxis Inc, Ratio Charts 27
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Advaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report